Omada Health
NASDAQ:OMDAMedical - Healthcare Information Services
+$0.13 today
- Market cap
- $817.04M
- Beta
- 2.09
- P/E (TTM)
- -162.6
- EPS (TTM)
- -$0.11
Volume 1.68M
Average 1.07M
OMDA Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Omada HealthNASDAQ: OMDA
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin widens to 62.4%
Gross margin was 62.4% in Q1 FY2026, up 4.3 pp from a year earlier. On a trailing-twelve-month basis it was 66.2%, up 4.6 pp year over year. Over 3 fiscal years it widened by 17.7 pp.
Context
- Gross margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 65.7%
- Year-over-year change
- +5.1pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 65.7% | +5.1pp |
| FY2024 | 2024-12-31 | 60.6% | +3.6pp |
| FY2023 | 2023-12-31 | 57.0% | +9.0pp |
| FY2022 | 2022-12-31 | 48.0% | — |
Gross Margin vs competitors
How OMDA compares with its peers on the latest reported figures
- OMDA's LTM Mar 2026 gross margin of 66.2% is the 2nd highest of the 5 companies compared; the peer median is 63.0%.
- Its year-over-year change of +4.6 pp is the 3rd highest of 5, against a peer median of +0.3 pp.
- Over three fiscal years its change of +17.7 pp compares with a peer median of +0.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 84.5% | +6.9 pp | — | |
| LTM Mar 2026 | 66.2% | +4.6 pp | +17.7 pp | |
| LTM Mar 2026 | 65.6% | -4.9 pp | +0.4 pp | |
| LTM Sep 2026 | 60.5% | -14.6 pp | -3.7 pp | |
| LTM Mar 2026 | 49.7% | +5.4 pp | +11.2 pp | |
| Peer median (excluding OMDA) | 63.0% | +0.3 pp | +0.4 pp | |
Competitors are the stored peer set for OMDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 89.19M | 122.78M | 169.8M | 260.21M |
| Cost of Revenue | 46.39M | 52.81M | 66.92M | 89.27M |
| Gross Profit | 42.79M | 69.97M | 102.88M | 170.94M |
| Gross Margin | 48.0% | 57.0% | 60.6% | 65.7% |
| Research & Development | 26.17M | 33.74M | 35.92M | 40.68M |
| Selling, General & Admin | 88.97M | 102.23M | 110.61M | 142.23M |
| Operating Expenses | 115.14M | 135.97M | 146.53M | 182.91M |
| Depreciation & Amortization | 4.33M | 4.45M | 4.8M | 5.49M |
| EBITDA | (63.99M) | (58.36M) | (37.83M) | (4.75M) |
| EBITDA Margin | -71.7% | -47.5% | -22.3% | -1.8% |
| Operating Income | (72.35M) | (66M) | (43.65M) | (11.97M) |
| Operating Margin | -81.1% | -53.8% | -25.7% | -4.6% |
| Interest Income | 2.2M | 5.78M | 805K | 5.31M |
| Interest Expense | 4.2M | 4.71M | 4.51M | 2.53M |
| Other Income / Expenses | (168K) | (1.51M) | (3.48M) | (806K) |
| Income Before Tax | (72.52M) | (67.51M) | (47.14M) | (12.78M) |
| Pre-Tax Margin | -81.3% | -55.0% | -27.8% | -4.9% |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | (72.52M) | (67.51M) | (47.14M) | (12.78M) |
| Net Margin | -81.3% | -55.0% | -27.8% | -4.9% |
| EPS (Basic) | (1.30) | (1.21) | (0.85) | (0.22) |
| EPS (Diluted) | (1.30) | (1.21) | (0.85) | (0.22) |
| Weighted Avg Shares | 55.74M | 55.74M | 55.74M | 58.43M |
| Weighted Avg Shares (Diluted) | 55.74M | 55.74M | 55.74M | 58.43M |
Omada Health
NASDAQ:OMDA
Intrinsic Alpha fair value
Locked
Current Price
$13.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.